Centro De Investigacion Cientifica Caucaseco LTDA
Doing business as Investigaciones Caucaseco LTDA
- UEI
- RBVYEZXND859
- CAGE
- SGQ08
- Primary NAICS
- 541380 Testing Laboratories and Services
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- inmuno.co
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Population Services International | 7200AA18C00014 | -$327,032 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Sanaria Inc. | Rockville, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| The Macfarlane Burnet Institute For Medical Research And Public Health LTD | Melbourne, VIC | 541720 Research and Development in the Social Sciences and Humanities |
| Infectious Diseases Research Collaboration | Kampala, Central Region | 621498 All Other Outpatient Care Centers |
| National Lutheran Health And Medical Board | Chennai, TN | — |
| Institut Pasteur | Paris, Île-de-France | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Centro De Investigacion Cientifica Caucaseco LTDA, doing business as Investigaciones Caucaseco LTDA, is a scientific research center focusing on biomedical, epidemiological, microbiological, immunological, and anthropological research. They have received two prime federal grants from the National Institutes of Health to support malaria vaccine development, including the discovery and preclinical evaluation of Plasmodium falciparum and P. vivax antigens, as well as the development and testing of protein nanoparticle vaccine constructs.
Centro De Investigacion Cientifica Caucaseco LTDA has received federal contract subawards from Population Services International to support Impact Malaria's work in Colombia. The specific goods and services provided through these subcontracts are not stated.
The federal grants received by Centro De Investigacion Cientifica Caucaseco LTDA aim to accelerate P. vivax vaccine development through the rational design and rigorous preclinical testing of highly efficacious vaccine candidates and protective human monoclonal antibodies that could be advanced to clinical evaluation. The $4 million cooperative agreement involves selecting and testing novel pre-erythrocytic stage antigens, evaluating their immunogenicity and protective efficacy in animal models, developing self-assembled protein nanoparticle constructs, and generating anti-P. vivax circumsporozoite protein human monoclonal antibodies. The $1.9 million project grant focuses on discovering and evaluating P. falciparum and P. vivax coiled coil antigens.
Quick answers
Is Centro De Investigacion Cientifica Caucaseco LTDA registered in SAM.gov?
Centro De Investigacion Cientifica Caucaseco LTDA's SAM.gov registration expired on November 10, 2022.
What is Centro De Investigacion Cientifica Caucaseco LTDA's most recent federal award?
Centro De Investigacion Cientifica Caucaseco LTDA's most recent federal grant award is Discovery and preclinical development of efficacious p. Vivax pre-erythrocytic stage malaria vaccines (U01AI155363), from National Institute of Allergy and Infectious Diseases (NIH), on November 20, 2020.
On GovTribe
See Centro De Investigacion Cientifica Caucaseco LTDA's full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors